Open Access
Open access
Cancers, volume 12, issue 1, pages 216

Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer

Kolovskaya Olga S 1, 2
Zamay Tatiana N. 1
Zamay Galina S 1, 2
Babkin Vasily A 3
Medvedeva Elena N 3
Neverova Nadezhda A 3
Kirichenko Andrey K. 1
Zamay Sergey S 2, 4
Lapin Ivan N 5
Morozov E. V. 4, 6
Sokolov Alexey E 4, 7
Narodov Andrey A 1
Tomilin Felix N. 2, 4, 9
Zabluda Vladimir N 4
Alekhina Yulia 10
Lukyanenko Kirill A. 1, 2, 11
Glazyrin Yury E. 1, 2
8
 
Research Center for Computational Design of Advanced Functional Materials (CD-FMat), National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568, Japan
12
 
Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada
Publication typeJournal Article
Publication date2020-01-15
Journal: Cancers
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor5.2
ISSN20726694
Cancer Research
Oncology
Abstract
Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer-functionalized magnetic nanoparticles exposed to a low frequency alternating magnetic field. We developed an enhanced targeting approach of cancer cells with aptamers and arabinogalactan. Aptamers to fibronectin (AS-14) and heat shock cognate 71 kDa protein (AS-42) facilitated the delivery of the nanoparticles to Ehrlich carcinoma cells, and arabinogalactan (AG) promoted internalization through asialoglycoprotein receptors. Specific delivery of the aptamer-modified FeAG nanoparticles to the tumor site was confirmed by magnetic resonance imaging (MRI). After the following treatment with a low frequency alternating magnetic field, AS-FeAG caused cancer cell death in vitro and tumor reduction in vivo. Histological analyses showed mechanical disruption of tumor tissues, total necrosis, cell lysis, and disruption of the extracellular matrix. The enhanced targeted magnetic theranostics with the aptamer conjugated superparamagnetic ferroarabinogalactans opens up a new venue for making biocompatible contrasting agents for MRI imaging and performing non-invasive anti-cancer therapies with a deep penetrated magnetic field.

Citations by journals

1
2
Materials
Materials, 2, 8%
Materials
2 publications, 8%
Magnetochemistry
Magnetochemistry, 2, 8%
Magnetochemistry
2 publications, 8%
ACS Applied Nano Materials
ACS Applied Nano Materials, 1, 4%
ACS Applied Nano Materials
1 publication, 4%
Biomedicines
Biomedicines, 1, 4%
Biomedicines
1 publication, 4%
Journal of Chemical Physics
Journal of Chemical Physics, 1, 4%
Journal of Chemical Physics
1 publication, 4%
Nucleic Acid Therapeutics
Nucleic Acid Therapeutics, 1, 4%
Nucleic Acid Therapeutics
1 publication, 4%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 4%
International Journal of Molecular Sciences
1 publication, 4%
Pharmaceutics
Pharmaceutics, 1, 4%
Pharmaceutics
1 publication, 4%
Journal of Clinical Medicine
Journal of Clinical Medicine, 1, 4%
Journal of Clinical Medicine
1 publication, 4%
Journal of Functional Biomaterials
Journal of Functional Biomaterials, 1, 4%
Journal of Functional Biomaterials
1 publication, 4%
Biosensors and Bioelectronics: X
Biosensors and Bioelectronics: X, 1, 4%
Biosensors and Bioelectronics: X
1 publication, 4%
Biomedical Materials (Bristol)
Biomedical Materials (Bristol), 1, 4%
Biomedical Materials (Bristol)
1 publication, 4%
Talanta
Talanta, 1, 4%
Talanta
1 publication, 4%
Advanced healthcare materials
Advanced healthcare materials, 1, 4%
Advanced healthcare materials
1 publication, 4%
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids, 1, 4%
Molecular Therapy - Nucleic Acids
1 publication, 4%
Journal of Chemical Theory and Computation
Journal of Chemical Theory and Computation, 1, 4%
Journal of Chemical Theory and Computation
1 publication, 4%
Acta Biomaterialia
Acta Biomaterialia, 1, 4%
Acta Biomaterialia
1 publication, 4%
Drug Delivery and Translational Research
Drug Delivery and Translational Research, 1, 4%
Drug Delivery and Translational Research
1 publication, 4%
Journal of Colloid and Interface Science
Journal of Colloid and Interface Science, 1, 4%
Journal of Colloid and Interface Science
1 publication, 4%
1
2

Citations by publishers

1
2
3
4
5
6
7
8
9
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 36%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 36%
Elsevier
Elsevier, 6, 24%
Elsevier
6 publications, 24%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 8%
American Chemical Society (ACS)
2 publications, 8%
Wiley
Wiley, 2, 8%
Wiley
2 publications, 8%
American Institute of Physics (AIP)
American Institute of Physics (AIP), 1, 4%
American Institute of Physics (AIP)
1 publication, 4%
Mary Ann Liebert
Mary Ann Liebert, 1, 4%
Mary Ann Liebert
1 publication, 4%
IOP Publishing
IOP Publishing, 1, 4%
IOP Publishing
1 publication, 4%
Springer Nature
Springer Nature, 1, 4%
Springer Nature
1 publication, 4%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Kolovskaya O. S. et al. Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer // Cancers. 2020. Vol. 12. No. 1. p. 216.
GOST all authors (up to 50) Copy
Kolovskaya O. S., Zamay T. N., Zamay G. S., Babkin V. A., Medvedeva E. N., Neverova N. A., Kirichenko A. K., Zamay S. S., Lapin I. N., Morozov E. V., Sokolov A. E., Narodov A. A., Fedorov D. V., Tomilin F. N., Zabluda V. N., Alekhina Y., Lukyanenko K. A., Glazyrin Y. E., Svetlichnyi V., Berezovski M. V., Kichkailo A. S. Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer // Cancers. 2020. Vol. 12. No. 1. p. 216.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/cancers12010216
UR - https://doi.org/10.3390%2Fcancers12010216
TI - Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer
T2 - Cancers
AU - Kolovskaya, Olga S
AU - Zamay, Galina S
AU - Babkin, Vasily A
AU - Neverova, Nadezhda A
AU - Kirichenko, Andrey K.
AU - Lapin, Ivan N
AU - Sokolov, Alexey E
AU - Narodov, Andrey A
AU - Zabluda, Vladimir N
AU - Zamay, Tatiana N.
AU - Medvedeva, Elena N
AU - Zamay, Sergey S
AU - Alekhina, Yulia
AU - Morozov, E. V.
AU - Fedorov, D. V.
AU - Tomilin, Felix N.
AU - Lukyanenko, Kirill A.
AU - Glazyrin, Yury E.
AU - Svetlichnyi, Valery
AU - Berezovski, Maxim V.
AU - Kichkailo, Anna S.
PY - 2020
DA - 2020/01/15 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 216
IS - 1
VL - 12
PMID - 31952299
SN - 2072-6694
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Kolovskaya,
author = {Olga S Kolovskaya and Galina S Zamay and Vasily A Babkin and Nadezhda A Neverova and Andrey K. Kirichenko and Ivan N Lapin and Alexey E Sokolov and Andrey A Narodov and Vladimir N Zabluda and Tatiana N. Zamay and Elena N Medvedeva and Sergey S Zamay and Yulia Alekhina and E. V. Morozov and D. V. Fedorov and Felix N. Tomilin and Kirill A. Lukyanenko and Yury E. Glazyrin and Valery Svetlichnyi and Maxim V. Berezovski and Anna S. Kichkailo},
title = {Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer},
journal = {Cancers},
year = {2020},
volume = {12},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {jan},
url = {https://doi.org/10.3390%2Fcancers12010216},
number = {1},
pages = {216},
doi = {10.3390/cancers12010216}
}
MLA
Cite this
MLA Copy
Kolovskaya, Olga S., et al. “Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer.” Cancers, vol. 12, no. 1, Jan. 2020, p. 216. https://doi.org/10.3390%2Fcancers12010216.
Found error?